We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Narcolepsy Treatment Study

This study is currently closed to enrollment.

Study to Evaluate Long-Term Safety and Tolerability of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) and the Ability to Switch from Twice-Nightly Immediate Release Sodium Oxybate to Once-Nightly FT218, or to begin once-Nightly FT218 for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy

woman leaning on beanbags

AGE: 16 years and older
GENDER: All
HEALTHY PARTICIPANTS: Yes
COMPENSATION: No
TYPE: Interventional Drug Study
CONDITION: Narcolepsy, Cataplexy, Sleep Disorder
LOCATION: University Hospitals Cleveland Medical Center

Purpose of Study

The purpose of this research study is to understand how safe the investigational drug is and how effective the drug is in reducing excessive daytime sleepiness and cataplexy in subjects with narcolepsy when taken long-term. The study will also evaluate how patients with narcolepsy who are or are not already on twice-nightly sodium oxybate or mixed salts oxybate can switch to FT218 in terms of what dosage should be prescribed.


STUDY ID#